|
Volumn 23, Issue 3, 2013, Pages 907-911
|
Novel benzoxazole inhibitors of mPGES-1
|
Author keywords
Benzoxazole; mPGES 1; Selective
|
Indexed keywords
3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID;
BENZOXAZOLE DERIVATIVE;
CYCLOOXYGENASE 2;
PROSTAGLANDIN E2;
PROSTAGLANDIN SYNTHASE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
COMPETITIVE INHIBITION;
CONTROLLED STUDY;
DOG;
DRUG BIOAVAILABILITY;
DRUG HALF LIFE;
ENZYME ASSAY;
HIGH THROUGHPUT SCREENING;
HUMAN;
HUMAN CELL;
HYDROLYSIS;
HYDROPHOBICITY;
IC 50;
IN VIVO STUDY;
MAXIMUM PLASMA CONCENTRATION;
NONHUMAN;
REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
STEREOCHEMISTRY;
STRUCTURE ACTIVITY RELATION;
TIME TO MAXIMUM PLASMA CONCENTRATION;
AMIDES;
ANIMALS;
BENZOXAZOLES;
BIOLOGICAL AVAILABILITY;
DOGS;
ENZYME ACTIVATION;
ENZYME INHIBITORS;
HUMANS;
INHIBITORY CONCENTRATION 50;
INTRAMOLECULAR OXIDOREDUCTASES;
MOLECULAR STRUCTURE;
STRUCTURE-ACTIVITY RELATIONSHIP;
CANIS FAMILIARIS;
|
EID: 84872305278
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2012.10.040 Document Type: Article |
Times cited : (25)
|
References (15)
|